Precision oncology – Guideline of the Austrian, German and Swiss Societies for hematology and medical oncology

IF 7.6 1区医学 Q1 ONCOLOGY European Journal of Cancer Pub Date : 2025-02-28 DOI:10.1016/j.ejca.2025.115331

Damian T. Rieke , Michael Bitzer , Annalen Bleckmann , Alexander Desuki , Thomas Ernst , Irene Esposito , Armin Gerger , Hanno Glimm , Peter Horak , Daniel Hübschmann , Anna Lena Illert , Volker Kunzmann , Sonja Loges , Ina Pretzell , Katja Schmitz , Andreas Seeber , Bärbel Söhlke , Andreas Wicki , Jürgen Wolf , Georg Maschmeyer

{"title":"Precision oncology – Guideline of the Austrian, German and Swiss Societies for hematology and medical oncology","authors":"Damian T. Rieke , Michael Bitzer , Annalen Bleckmann , Alexander Desuki , Thomas Ernst , Irene Esposito , Armin Gerger , Hanno Glimm , Peter Horak , Daniel Hübschmann , Anna Lena Illert , Volker Kunzmann , Sonja Loges , Ina Pretzell , Katja Schmitz , Andreas Seeber , Bärbel Söhlke , Andreas Wicki , Jürgen Wolf , Georg Maschmeyer","doi":"10.1016/j.ejca.2025.115331","DOIUrl":null,"url":null,"abstract":"<div><div>Precision oncology is a multi-step process including patient selection, tumor profiling, molecular tumor board discussion and personalized cancer management. So far, it remains largely unstandardized. The implementation of precision oncology can be beneficial for patients but implementation differs widely between tumor types and local practices. A working group was established by the Austrian, German and Swiss societies for Hematology and Medical Oncology to establish an expert consensus on evidence-based standards and implementation of precision oncology. Herein, we present a summary of this guideline. The full documents are available at www.onkopedia-guidelines.info</div></div>","PeriodicalId":11980,"journal":{"name":"European Journal of Cancer","volume":"220 ","pages":"Article 115331"},"PeriodicalIF":7.6000,"publicationDate":"2025-02-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0959804925001121","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Precision oncology is a multi-step process including patient selection, tumor profiling, molecular tumor board discussion and personalized cancer management. So far, it remains largely unstandardized. The implementation of precision oncology can be beneficial for patients but implementation differs widely between tumor types and local practices. A working group was established by the Austrian, German and Swiss societies for Hematology and Medical Oncology to establish an expert consensus on evidence-based standards and implementation of precision oncology. Herein, we present a summary of this guideline. The full documents are available at www.onkopedia-guidelines.info

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

求助全文

约1分钟内获得全文去求助

来源期刊

European Journal of Cancer 医学-肿瘤学

CiteScore

11.50

自引率

4.80%

发文量

953

审稿时长

23 days

期刊介绍： The European Journal of Cancer (EJC) serves as a comprehensive platform integrating preclinical, digital, translational, and clinical research across the spectrum of cancer. From epidemiology, carcinogenesis, and biology to groundbreaking innovations in cancer treatment and patient care, the journal covers a wide array of topics. We publish original research, reviews, previews, editorial comments, and correspondence, fostering dialogue and advancement in the fight against cancer. Join us in our mission to drive progress and improve outcomes in cancer research and patient care.